Effects of glutamate transport substrates and glutamate receptor ligands on the activity of Na+/K+-ATPase in brain tissue in vitro

Clinical and Experimental Pharmacology and Physiology

Volumn 31, Issue 11, 2004, Pages 762-769

  Nanitsos, Ellas K ^a   Acosta, Gabriela B ^a,b   Saihara, Yukiko ^a   Stanton, David ^a   Liao, Lee P ^a   Shin, Jae W ^a   Rae, Caroline ^a   Balcar, Vladimir J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Instituto de Investigaciones Farmacologicas   (Argentina)

Author keywords

Brain energy metabolism; Excitatory amino acid transporter substrates and inhibitors; Na+ and K+ dependent transport of L glutamate; Na+ K+ ATPase; Rb+ uptake

Indexed keywords

(TETRAZOL 5 YL)GLYCINE; 2 (CARBOXYCYCLOPROPYL)GLYCINE; 2,4 PYRROLIDINEDICARBOXYLIC ACID; 3,4 METHANOPYRROLIDINE DICARBOXYLIC ACID; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ASPARTIC ACID; DEXTRO ASPARTIC ACID; DIHYDROKAINIC ACID; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR AGONIST; GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; OUABAIN; PYRROLIDINE DERIVATIVE; RUBIDIUM; THREO 3 BENZYLOXYASPARTIC ACID; UNCLASSIFIED DRUG;

AMINO ACID TRANSPORT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; ATOMIC ABSORPTION SPECTROMETRY; BRAIN CORTEX; BRAIN METABOLISM; BRAIN SLICE; BRAIN TISSUE; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENERGY METABOLISM; ENZYME ACTIVITY; FEMALE; IN VITRO STUDY; MALE; NEUROTOXICITY; NONHUMAN; RAT; SYNAPSE;

AMINO ACID TRANSPORT SYSTEM X-AG; ANIMALS; ASPARTIC ACID; BRAIN; ENZYME INHIBITORS; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GLUTAMIC ACID; IONOPHORES; LIGANDS; MALE; MICROSCOPY, ELECTRON; NA(+)-K(+)-EXCHANGING ATPASE; NEUROTOXINS; OUABAIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUTAMATE; RUBIDIUM; SPECTROPHOTOMETRY, ATOMIC; SYNAPTIC TRANSMISSION;

EID: 9344239409     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2004.04090.x     Document Type: Article

References (56)

1. Danbolt NC. Glutamate uptake. Prog. Neurobiol. 2001; 65: 1-105.
2. Vandenberg RJ. Molecular pharmacology and physiology of glutamate transporters in the central nervous system. Clin. Exp. Pharmacol. Physiol. 1998; 25: 393-400.
3. +-dependent transport of acidic amino acids in the mammalian central nervous system. Biol. Pharm. Bull. 2002; 25: 291-301.
4. O'Shea RD. Roles and regulation of glutamate transporters in the central nervous system. Clin. Exp. Pharmacol. Physiol. 2002; 29: 1018-23.
5. Rae C, Lawrance ML, Dias LS, Provis T, Bubb WA, Balcar VJ. Strategies for studies of neurotoxic mechanisms involving deficient glutamate transport of L-glutamate: Antisense knockout in rat brain in vivo and changes in neurotransmitter metabolism following inhibition of glutamate transport in guinea pig brain slices. Brain Res. Bull. 2000; 53: 373-81.
6. Rae C, Hare N, Bubb WA et al. Inhibition of glutamine transport depletes glutamate and GABA neurotransmitter pools: Further evidence for metabolic compartmentation. J. Neurochem. 2003; 85: 503-14.
7. Moussa CE-H, Mitrovic AD, Vandenberg RJ et al. Effects of L-glutamate transport inhibition by a conformationally restricted glutamate analogue (2S,1′S,2′R)-2-(carboxycyclopropyl)-glycine (L-CCG III) on metabolism in brain tissue in vitro analysed by NMR spectroscopy. Neurochem. Res. 2002; 27: 27-35.
8. Blitzblau R, Gupta S, Djali S, Robinon M, Rosenberg PA. The glutamate transport inhibitor 1-trans-pyrrolidine-2,4-dicarboxylate indirectly evokes NMDA receptor mediated neurotoxicity in rat cortical cultures. Eur. J. Neurosci. 1996; 8: 1840-52.
9. Rothstein JD, Dykes-Hoberg M, Pard CA et al. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 1996; 16: 675-86.
10. Sanchez-Carbente MR, Massieu L. Transient inhibition of glutamate uptake in vivo induces neurodegeneration when energy metabolism is impaired. J. Neurochem. 1999; 72: 129-38.
11. Garcia O, Massieu L. Strategies for neuroprotection against 1-trans-pyrrolidine-2,4-dicarboxylate-induced neuronal damage during energy impairment in vitro. J. Neurosci. Res. 2001; 64: 418-28.
12. +-dependent glutamate transporters in the mammalian CNS. Adv. Pharmacol. 1997; 37: 69-115.
13. Danbolt NC. Sodium- and potassium-dependent excitatory amino acid transporters in brain plasma membranes. In: Björklund A, Hökfelt T (eds). Handbook of Chemical Neuroanatomy, Vol. 18: Glutamate. Elsevier, Amsterdam. 2000; 231-54.
14. Hertz L, Dringen R, Schousboe A, Robinson SR. Minireview. Astrocytes: Glutamate producers for neurons. J. Neurosci. Res. 1999; 57: 417-28.
15. + dynamics in mouse cortical astrocytes: Implications for cellular bioenergetics. Eur. J. Neurosci. 2000; 12: 3843-53.
16. Balcar VJ, Johnston GAR. The structural specificity of the high affinity uptake of L-glutamate and L-aspartate by rat brain slices. J. Neurochem. 1972; 19: 2657-66.
17. Balcar VJ, Borg J, Mandel P. High affinity uptake of L-glutamate and L-aspartate by glial cells. J. Neurochem. 1977; 28: 87-93.
18. +-ATPase activity in astrocytes via activation of a distinct subunit highly sensitive to ouabain. J. Neurochem. 1997; 69: 2132-7.
19. Balcar VJ, Takamoto A, Yoneda Y. Neurochemistry of L-glutamate transport in the CNS. A review of thirty years of progress. Collect. Czech. Chem. Commun. 2001; 66: 1315-40.
20. Mcilwain H, Bachelard H. Biochemistry and the Central Nervous System. Churchill Livingstone, Edinburgh. 1985.
21. 13C NMR spectroscopy. Biochem. J. 1990; 266: 133-9.
22. Balcar VJ, Johnston GAR. Ontogeny of high affinity uptake of GABA studied in 'minislices' (tissue prisms) of rat cerebral cortex. Dev. Brain Res. 1989; 49: 295-9.
23. 3H]GABA in rat cerebral cortex studied by a simple technique in vitro. Neurochem. Int. 1986; 8: 573-80.
24. Balcar VJ, Johnston GAR. Liberation of amino acids during the preparation of brain slices. Brain Res. 1975; 83: 173-5.
25. Munson PJ, Rodbard D. LIGAND. A versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 1980; 107: 220-39.
26. McGonigle P, Molinoff PB. Quantitative aspects of drug-receptor interactions. In: Siegel GJ, Agranoff BW, Albers RW, Molinoff PB (eds). Basic Neurochemistry. Raven Press, New York. 1989; 183-202.
27. Shimamoto K, Lebrun B, Yasuda-Kamatani Y et al. DL-threo-β- Benzyloxyaspartate, a potent blocker of excitatory amino acid transporters. Mol. Pharmacol. 1998; 53: 195-201.
28. +- dependent transporter in the forebrain synaptosomes: 1-anti,endo-3,4- Methanopyrrolidine dicarboxylate. Neurosci. Lett. 1994; 174: 193-7.
29. Bridges RJ, Stanley MS, Anderson MW, Cotman CW, Chamberlain AR. Conformationally defined neurotransmitter analogues. Selective inhibition of glutamate uptake by one pyrrolidine-2,4-dicarboxylate diastereoisomer. J. Med. Chem. 1991; 34: 717-25.
30. Bridges RJ, Kavanaugh MP, Chamberlain AR. A pharmacological review of competitive inhibitors and substrates of high affinity, sodium dependent glutamate transport in the central nervous system. Curr. Pharm. Des. 1999; 5: 363-79.
31. Shimamoto K, Ohfune Y. Syntheses and conformational analyses of glutamate analogs: 2-(2-Carboxy-3-substituted-cyclopropyl) glycines as useful probes for excitatory amino acid receptors. J. Med. Chem. 1996; 39: 407-23.
32. Nakamura Y, Kataoka K, Ishida M, Shinozaki H. (2S,3S,4R)-2- (Carboxycyclopropyl) glycine, a potent and competitive inhibitor of both glial and neuronal uptake of glutamate. Neuropharmacology 1993; 32: 833-7.
33. Stanton D, Liao L, Rae C, Bubb WA, Moussa CE-H, Balcar VJ. Can inhibition of glutamate transport contribute to the action of neuroleptics? Psychiatrie 2003; 7: 6-11.
34. Balcar VJ, Johnston GAR, Twitchin B. Stereospecificity of the inhibition of L-glutamate and L-aspartate high affinity uptake in rat brain slices by threo-3-hydroxyaspartate. J. Neurochem. 1977; 28: 1145-6.
35. Johnston GAR, Kennedy SME, Twitchin B. Action of neurotoxin kainic acid on high affinity uptake of L-glutamic acid in rat brain slices. J. Neurochem. 1979; 32: 121-8.
36. Cooper B, Chebib M, Shen J et al. Structural selectivity and molecular nature of L-glutamate transport in cultured human fibroblasts. Arch. Biochem. Biophys. 1998; 353: 356-64.
37. +-dependent binding sites on glutamate transporters in frozen sections of rat brain. Life Sci. 2002; 70: 991-1001.
38. Ransnas LA, Motulsky HJ. Fitting curves to data using non-linear regression. A practical and non-mathematical review. FASEB J. 1987; 1: 365-74.
39. Yamada KA, Tang C-M. Benzothiadiazides inhibit rapid glutamate desensitization and enhance rapid glutamatergic synaptic currents. J. Neurosci. 1993; 13: 3904-15.
40. Zorumski CF, Yamada KA, Price MT, Olney JW. A benzodiazepine recognition site associated with the non-NMDA glutamate receptor. Neuron 1993; 10: 61-7.
41. Schoepp DD, Smith CG, Lodge D et al. L-(Tetrazol-5-yl) glycine. A novel and highly potent NMDA receptor agonist. Eur. J. Pharmacol. 1991; 203: 237-43.
42. Neale JH, Bzdega T, Wroblewska B. N-Acetylaspartylglutamate: The most abundant peptide neurotransmitter in the mammalian central nervous system. J. Neurochem. 2000; 75: 553-62.
43. De Blasi A, Conn PJ, Pin J-P, Nicoletti F. Molecular determinants of metabotropic glutamate receptor signalling. Trends Pharmacol. Sci. 2001; 22: 114-19.
44. +-ATPase. Biochim. Biophys. Acta 1985; 988: 185-220.
45. +-ATPase, heterogeneity in structure, diversity and function. Am. J. Physiol. 1998; 275: F633-50.
46. +-ATPase. Arch. Biochem. Biophys. 1994; 310: 32-9.
47. +-ATPase isozymes in neurons and glia. Can. J. Physiol. Pharmacol. 1992; 70 (Suppl.): S255-9.
48. +-ATPase α and β subunits. Mol. Brain. Res. 1994; 21: 599-603.
49. Balcar VJ, Schousboe A, Spoerri PE, Wolff JR. Differences between substrate specificities of L-glutamate uptake by neurons and glia, studied in cell lines and primary cultures. Neurochem. Int. 1987; 10: 213-18.
50. + pump in L-glutamate clearance by cultured rat cortical astrocytes. Biol. Pharm. Bull. 2000; 23: 1051-4.
51. +-ATPase activity in cultured astrocytes. FEBS Lett. 2003; 534: 115-18.
52. +-ATPase alpha 2-subunit and the glutamate transporters GLAST and GLT in the rat somatosensory cortex. Cereb. Cortex 2002; 12: 515-25.
53. Cholet N, Pellerin L, Welker E et al. Local injection of antisense oligonucleotides targeted to the glial glutamate transporter GLAST decreases the metabolic response to somatosensory activation. J. Cereb. Blood Flow 2001; 21: 404-12.
54. Balcar VJ. Effects of variations in ionic concentrations on high affinity uptake of L-glutamate in non-glutamatergic neurons and non-neuronal cells cultured from neonatal rat cortex. Neurochem. Internat 1991; 18: 43-9.
55. Gottlieb M, Wang Y, Teichberg VI. Blood-mediated scavenging of cerebrospinal fluid glutamate. J. Neurochem. 2003; 87: 119-26.
56. Pliss L, Škultétyová I, Ježová D, Balcar VJ, Št'astný F. N-Acetyl-L-aspartyl-L-glutamate (NAAG) changes functional and structural properties of rat blood-brain barrier. Neurosci. Lett. 2002; 317: 85-8.